In the specialized field of biochemical research, navigating the nomenclature of various compounds can be complex. When researchers ask, "what is 3 mog peptide," they are often referring to the specific study of MOG peptides—specifically the MOG (35-55) fragment. It is important t Patient-Derived Monoclonal Myelin Oligodendrocyte o clarify that this is a research-grade tool used strictly in controlled laboratory settings, such as immunology and neuroscience studies, and is not for personal or human use.
Defining the MOG Peptide Entity
Myelin oligodendrocyte glycoprotein (MOG) is a membrane-bound glycoprotein that plays a significant role in the structure of the central nervous system. It is a transmembrane protein expressed on the surface of oligodendrocyte cells and is found on the outermost surface of myelin sheaths.
The specific fragment often discussed, MOG Protein (35-55), represents a high quality epitope peptide. In academic literature, you will often find three distinct variations of these sequences being evaluated for their specific biological properties. Scientists utilize these sequences because MOG is a glycoprotein MOG Antibody Disease Information uniquely expressed in oligodendrocyte membranes and myelin sheath, making it an essential subject for studying immune system interactions within the nervous system.
The Role of MOG (35-55) in Research Models
The MOG (35-55) peptide is widely recognized for its use as an antigen/immunogen in experimental models. Because MOG (35-55) is highly encephalitogenic, it is frequently employed in laboratory settings to study immune-mediated responses.
When researchers examine MOG 35-55 human sequences (MEVGWYRPPFSRVVHLYRNGK) versus murine variants, they are looking at how these sequences trigger specific T and B cell responses. In these controlled environments, the administration of the peptide is designed to mimic aspects of neuroinflammatory processes. For instance, studies have shown that MOG (35-55) produces a relapsing-remitti MOG Protein (35-55), Myelin Oligodendrocyte Glycoprotein ng neurological disease in specific animal models, which allo MOG Protein (35-55), MOG Peptide Fragment, human ws investigators to observe the mechanisms of myelin degradation or the development of MOG Antibody Disease (MOGAD) markers in a laboratory context.
Technical Specifications and Variations
When sourcing these materials for research, precision is paramount. Whether dealing with the murine or human variant, the purity of the Myelin oligodendrocyte glycoprotein (MOG) peptide is critical for consistent results.
* Structure: It is a type of protein involved in cell adhesion.
* Molecular Context: As a membrane-bound glycoprotein, it provides a scaffold for studying how the immune system recognizes self-antigens.
* Experimental Utility: Researchers often use Myeli by P Peschl · 2017 · Cited by 300 — Myelin oligodendrocyte glycoprotein (MOG), a member of the immunoglobulin (Ig) superfamily, is a myelin protein solely expressed at the outermost surface of n Oligodendrocyte Glycoprotein Peptide (35-55) to investigate the efficacy of potential therapeutic candidates, such as the Myelin Oligodendrocyte Glycoprotein (MOG)35–55 Mannan Conjugate, which aims to modulate immune responses.
Observations on Research Applications
My personal interest in this field stems from observing how the 3 most common MOG peptide variants are used to map the landscape of protein-ligand interactions. It is fascinating to see how Myelin oligodendrocyte glycoprotein MOG (35-55) serves as a foundational tool for understanding how the body maintains the integrity of the CNS.
While the scientific community continues to explore the nuances of these peptides—including their role in The Mouse Myelin-oligodendrocyte glycoprotein Peptide is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays. omyelitis-related research and broader ne The MOG peptide (35-55) has been described to induce autoimmune encephalomyelitis associated with Parkinson disease. uro-immunological studies—it remains clear that these tools are strictly for the advancement of our understanding of protein function. The complexity of how these proteins interact with the immune system is a testament to the pre MOG Protein 35-55, MOG Peptide Fragment human cision required in modern biochemical research, necessitating high-purity, well-characterized sequences for every experiment.
By focusing on these specific protein fragments, researchers can continue to decipher the intricate relationship between the CNS and immune surveillance, moving closer to the mechanisms that define these complex biological interactions.